Pharmacy alerts

Viatris Products Ltd, Arixtra solution for injection, pre-filled syringes defect

Class 4 medicines defect notification: The MHRA has published a Class 4 medicines defect notification for Arixtra solution for injection, pre-filled syringes.

Blumont Pharma Limited, Ocumont Eye Ointment 1% w/w defect

Class 4 medicines defect notification: The MHRA has published a Class 4 medicines defect notification for Ocumont Eye Ointment 1% w/w.

Isotretinoin – changes to prescribing guidance and additional risk minimisation measures

Drug Safety Update: CHM has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023.

Glenmark Pharmaceuticals Europe Limited, Fingolimod Glenmark 0.5 mg hard capsules recall

Class 3 medicines recall: The MHRA has published a Class 3 recall for Fingolimod Glenmark 0.5 mg hard capsules.

Mercury Pharmaceuticals Ltd, Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes recall

Class 2 medicines recall: The MHRA has published a Class 2 medicines recall for Paliperidone 50mg, 75mg, 100mg and 150mg prolonged-release suspension for injection in pre-filled syringes.

Epimax Ointment and Epimax Paraffin-Free Ointment – reports of ocular surface toxicity and ocular chemical injury

Drug Safety Update reminder: The MHRA is continuing to receive reports of ocular surface toxicity and ocular chemical injury for these emollients.